Ondine Biomedical Inc. Announces Steriwave in First Swiss Hospital

April 8, 2025 2:00 AM

Ondine Biomedical Inc. (LON: OBI) reports that University Hospital Zurich (USZ) has initiated an independent clinical study evaluating Steriwave®. This marks the first Swiss deployment of Ondine's nasal decolonization technology to combat surgical site infections (SSI).The study, titled "Preoperative Microbial Reduction of the Nasal Cavity with Antimicrobial Photodynamic Therapy (aPDT)," is led by Professor Dr. Harald Essig, Head of the...

Read more

2025 Mexico EHR Market Report: Technology Growth Amid Structural and Regulatory Barriers, Released by Black Book Research

April 7, 2025 9:45 PM

Mexico's Electronic Health Record (EHR) sector is experiencing steady growth as healthcare providers, health systems, and policymakers continue to prioritize digital transformation initiatives. According to the 2025 Mexico EHR Market Report by Black Book, survey responses from 187 physician practices and 220 hospital managers reveal a growing interest in EHR systems across both public and private healthcare institutions. Despite this progress,...

Read more

Glidewell Dental Laboratory Partners With Swiss Implant Company TRI

April 7, 2025 12:00 PM

Glidewell, a comprehensive provider of surgical and restorative dental implant solutions, announced a new partnership with Swiss-based implant company, TRI - a global manufacturer of dental implant fixtures. This alliance aims to give users of TRI matrix implants access to the production and support capabilities of Glidewell dental lab - one of the most experienced validated milling centers in dentistry.TRI's products include implant systems...

Read more

Ankle & Foot Centers of America Offers Tips for National Foot Health Awareness Month

April 7, 2025 9:01 AM

People often overlook the health of their feet, but even minor problems can cause pain, reduce mobility, hinder activities and diminish quality of life. During National Foot Health Awareness Month, Ankle & Foot Centers of America encourages preventive care strategies such as routine foot check-ups, proper footwear, and daily hygiene to avoid complications that could lead to more serious medical conditions."Your feet are the foundation of your...

Read more

CureVac Receives U.S. FDA IND Clearance to Initiate Phase 1 Clinical Trial for Novel mRNA-Based Precision Immunotherapy in Squamous Non-Small Cell Lung Cancer

April 7, 2025 7:15 AM

CureVac N.V. (Nasdaq:CVAC) ("CureVac"), a global biotech company developing a new class of transformative medicines based on messenger ribonucleic acid ("mRNA"), today announced that the U.S. Food and Drug Administration (FDA) has cleared its Investigational New Drug (IND) application for a Phase 1 clinical study of CVHNLC in patients with squamous non-small cell lung cancer (sqNSCLC). CVHNLC is CureVac's investigational mRNA-based precision...

Read more

Moderna to Showcase Extensive Infectious Disease Research at ESCMID 2025

April 7, 2025 7:00 AM

Moderna, Inc. (NASDAQ:MRNA) today announced that the Company will present research across multiple infectious disease areas, including COVID-19, influenza, respiratory syncytial virus (RSV), cytomegalovirus (CMV), norovirus, and mpox, at the European Society of Clinical Microbiology and Infectious Diseases (ESCMID) Global Congress in Vienna, Austria, from April 11-15, 2025.Moderna will present twelve scientific presentations at the ESCMID 2025...

Read more

DEA Marijuana Enforcers Fail the Law: The DEA Chief Council Attorney Aarathi Haig Not in Good Standing

April 7, 2025 5:00 AM

The United States Drug Enforcement Administration (DEA), the federal agency tasked with enforcing the nation's controlled substances marijuana laws and pharmaceutical development, now finds itself in the center of a growing controversy that threatens its credibility. The issue isn't just about MMJ BioPharma Cultivations bureaucratic delays that have stalled vital medical marijuana research-it's about the integrity of the very individuals charged...

Read more

New Data Bolstering the Anti-inflammatory Effect of NeuroRestore ACD856 Presented at Alzheimer's Conference

April 7, 2025 4:12 AM

AlzeCure Pharma AB (publ) (FN STO:ALZCUR), a pharmaceutical company that develops candidate drugs for diseases affecting the nervous system, focusing on Alzheimer's disease and pain, announced today that the company's presentation at the AD/PD 2025 scientific conference is now available in its entirety on the company's website. The presentation includes new preclinical data with the company's lead drug candidate NeuroRestore ACD856, which is...

Read more

IRLAB Presents at Two Redeye Events

April 7, 2025 1:20 AM

IRLAB Therapeutics AB (Nasdaq Stockholm:IRLAB A), a company discovering and developing novel treatments for Parkinson's disease, today announces that Kristina Torfgård, CEO and Viktor Siewertz, CFO will present the latest from IRLAB's pipeline at Redeye Theme: Alzheimer's & Parkinson's on April 8 and at Redeye Investor Forum in Gothenburg on April 10, respectivly.Redeye Theme: Alzheimer's & Parkinson's will be held at Redeye Headquarters, Mäster...

Read more

World Health Day: ATS Medical and Telemedicine Expand the Reach of Care

April 7, 2025 1:00 AM

"As we note the importance of improving public health for World Health Day on April 7, it is worth recognizing telehealth's innovations in extending the delivery of quality health care," says Dr. Majd Karazoun, General Manager of ATS Medical. Her firm is a leader in driving these innovations, she explains."ATS Medical is revolutionizing remote care with portable medical monitors and telehealth platforms, ensuring high-quality healthcare reaches...

Read more

Sea Pharmaceuticals Announces Strategic Relationship to Advance Treatments For Patients with CNS Disorders

April 6, 2025 6:05 PM

CAMBRIDGE, MA / ACCESS Newswire / April 6, 2025 / Sea Pharmaceuticals, LLC (Sea) today announced its selection of Inotiv Inc. (NASDAQ:NOTV) for pre-clinical development IND-enabling studies to support the advancement of Sea's lead molecule SPM-0404 as a potential new oral medicine to treat tinnitus, epilepsy and S-ALS. Sea's SPM-0404 and a second-generation molecule SPM-0606 represent a portfolio strategy of discovery and development of potent,...

Read more

Whittier Street Health Center in Boston is Expanding Its Health on Wheels Program

April 6, 2025 9:00 AM

As part of its ongoing commitment to improving medical care accessibility, Whittier Street Health Center, a community health center with a mission to serve as a center of excellence that provides high quality and accessible health care and social services that achieve health equity, social justice, and the economic well-being of a diverse patient population, announces the launch of its new Mobile Dental and Vision Service.With the introduction...

Read more

Breaking: DEA Attorney in MMJ Marijuana Case Lacks Good Standing in Bar, Raising Ethical Concerns

April 6, 2025 6:30 AM

New Jersey Bar records obtained by MMJ International Holdings reveal that Aarathi D. Haig, a DEA attorney central to the agency's controversial handling of MMJ Biopharma Cultivation's Bulk Manufactures cannabis research application, is not in good standing with the New Jersey Bar. A February 2023 letter from the New Jersey Board of Bar Examiners states Aarathi Haig is ineligible for a Certificate of Good Standing due to:Failure to pay mandatory...

Read more

American College of Osteopathic Family Physicians Honors 2025 Outstanding Members of the Profession

April 5, 2025 2:00 PM

The American College of Osteopathic Family Physicians (ACOFP), the ACOFP Foundation, and the Auxiliary to the ACOFP recognized 2025 award winners at the ACOFP 62nd Annual Convention & Scientific Seminars, April 2-6, 2025, in Palm Springs, California.ACOFP's awards program honors in-practice physicians, residents, and students who make exemplary contributions to the field of osteopathic medicine.ACOFP award recipients include:Osteopathic Family...

Read more

From the Bedside to the Boardroom: Former MetroHealth CEO, Dr. Airica Steed's Visionary Journey in Healthcare

April 4, 2025 7:00 PM

Dr. Airica Steed's career is as inspiring as it is groundbreaking. A true trailblazer, Dr. Airica Steed exemplifies what it means to lead with purpose, passion, and a vision for change. Her life's work is anchored in a multi-generational legacy of caregiving and an unyielding determination to reshape healthcare for the greater good. As the first Black, female, and nurse CEO of MetroHealth, she embodies a unique blend of lived experience,...

Read more

UniDoc Announces LIFE Offering

April 4, 2025 6:15 PM

UniDoc Health Corp. (CSE:UDOC) ("UniDoc" or the "Company") is pleased to announce a non-brokered private placement LIFE offering (the "Offering") for total gross proceeds of up to $500,000, consisting of up to 2,000,000 units of the Company (each, a "Unit") at a price of $0.25 per Unit.Each Unit will consist of one common share in the capital of the Company and one-half of one transferrable common share purchase warrant (a "Warrant"). Each...

Read more

Jaguar Health Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

April 4, 2025 4:15 PM

Jaguar Health, Inc. (NASDAQ:JAGX) ("Jaguar" or the "Company") today announced that, effective April 3, 2025, the Company granted 3,600 restricted stock units (RSUs) to New Employee 1, 3,600 RSUs to New Employee 2, 600 RSUs to New Employee 3, 100 RSUs to New Employee 4, 600 RSUs to New Employee 5, and 600 RSUs to New Employee 6.The RSUs for New Employees 1 and 2 vest over three years, with one-third of the RSUs vesting each year starting from...

Read more

Aptevo Therapeutics Announces the Closing of $2.1 Million Registered Direct Offering and Concurrent Private Placement Priced At-The-Market Under Nasdaq Rules

April 4, 2025 4:05 PM

Aptevo Therapeutics Inc. (Nasdaq:APVO) ("Aptevo" or the "Company"), a clinical-stage biotechnology company focused on developing novel immune-oncology therapeutics based on its proprietary ADAPTIR™ and ADAPTIR-FLEX™ platform technologies, announced the closing of its previously announced offering of 1,764,710 shares of the Company's common stock in a registered direct offering and warrants to purchase up to 3,529,420 shares of common stock in a...

Read more

France's EHR Revolution: AI, Compliance, and Interoperability Drive 2025 Trends, Reports Black Book

April 4, 2025 4:00 PM

France's Electronic Health Record (EHR) sector is undergoing significant transformation, according to survey findings released by Black Book Research. Feedback from 195 French healthcare IT and clinical operations professionals between Q3 2024 and Q1 2025 reveals a nationwide shift toward integrated platforms, enhanced interoperability, and compliance with stringent data protection regulations.Market Consolidation and Interoperability Take...

Read more

Royal Biologics Withdraws From the Alliance of Wound Care Stakeholders Over Support for Restrictive LCD Policies

April 4, 2025 2:00 PM

Royal Biologics, a leader in regenerative biologic technologies and wound care solutions, today announced its formal decision to part ways with the Alliance of Wound Care Stakeholders. This move comes in response to the Alliance's continued support of newly adopted Local Coverage Determinations (LCDs) that Royal Biologics believes threaten fair competition, increase costs, and limit patient access to critical treatment options.The updated LCDs...

Read more